A common refrain since GLP-1 weight-loss drugs hit the market is that the price of treatments has led many employers to hesitate about providing access to the drugs through company health plans. In ...

The MarketWatch News Department was not involved in the creation of this content. TORONTO, March 5, 2026 /CNW/ - A Women's Work (AWW Org) today announced the launch of the MODWORKS Program: 2026 ...

In the world, where India ranks second when it comes to obesity, the skinny jab has become the most sought-after way to lose weight. From Hollywood red carpets to the pharmacies of South Delhi and ...

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid major weight regain in real-world settings. Researchers say many patients ...

A doctor has issued a stark warning to anyone considering weight loss injections about the "most common" side effect he sees in patients. The expert described it as "absolutely miserable". These ...

A doctor issued a warning to anyone “considering” using weight loss jabs about the “most common” side effect he sees in patients. According to the expert, this can be “absolutely miserable”. These ...

Discovering the best protein bars for Weight Watchers can be a game-changer in your weight loss journey. These convenient, nutritious snacks are not just a quick bite but a strategic tool for wisely ...

The new platform lets employers offer GLP-1 drugs like Zepbound at a discounted rate while choosing from a marketplace of administrators. GLP-1 weight-loss drugs have quickly become some of the most ...